Comparative efficacy of azithromycin versus clarithromycin in combination with beta-lactams to treat community-acquired pneumonia in hospitalized patients: a systematic review

Comparative efficacy of azithromycin versus clarithromycin in combination with beta-lactams to treat community-acquired pneumonia in hospitalized patients: a systematic review

Objective The objective was to compare the efficacy of azithromycin and clarithromycin in combination with beta-lactams to treat community-acquired pneumonia among hospitalized adults. Methods Five databases (PubMed, Google Scholar, Trip, Medline, and Clinical Key) were searched to identify randomiz...

Full description

Bibliographic Details
Main Authors:	Jumana Al-Salloum, Syed Wasif Gillani, Rana Kamran Mahmood, Shabaz Mohiuddin Gulam
Format:	Article
Language:	English
Published:	SAGE Publishing 2021-10-01
Series:	Journal of International Medical Research
Online Access:	https://doi.org/10.1177/03000605211049943

Similar Items

Scholarly pathway: Understanding, planning, and competency mapping in pharmacy education
by: Syed Wasif Gillani, et al.
Published: (2020-01-01)

Assessment methods and competency mapping in pharmacy education: Understanding of components and quality parameters
by: Syed Wasif Gillani, et al.
Published: (2021-01-01)

The effect of erythromycin and clarithromycin versus azithromycin on serum valproate concentration
by: Muradi Albanji, et al.
Published: (2022-04-01)

Choice of Antimicrobials in Surgical Prophylaxis - Overuse and Surgical Site Infection Outcomes from a Tertiary-Level Care Hospital
by: Prasanna Vippadapu, et al.
Published: (2022-04-01)

Comparative efficacy of empagliflozin versus placebo in the treatment of type 1 diabetes mellitus: a meta-analysis of randomized controlled trials
by: Gillani Syed Wasif, et al.
Published: (2021-09-01)

Azithromycin in the Treatment of Community-acquired Pneumonia in Children
by: N. I. Zryachkin, et al.
Published: (2016-04-01)

Systematic Review: Study of the Prescribing Pattern of Antibiotics in Outpatients and Emergency Departments in the Gulf Region
by: Rana Kamran Mahmood, et al.
Published: (2020-12-01)

Procalcitonin predicts response to beta-lactam treatment in hospitalized children with community-acquired pneumonia.
by: Jérémie F Cohen, et al.
Published: (2012-01-01)

The in vitro effects of azithromycin and clarithromycin on promastigotes and amastigotes of leishmania tropica
by: BALCIOGLU IC, et al.
Published: (2012-03-01)

Therapeutic efficacy of azithromycin, clarithromycin, minocycline and tosufloxacin against macrolide-resistant and macrolide-sensitive Mycoplasma pneumoniae pneumonia in pediatric patients.
by: Nobuhisa Ishiguro, et al.
Published: (2017-01-01)

Clarithromycin for community-acquired pneumonia in adults: focus on anti-inflammatory properties
by: Alexander I. Sinopalnikov, et al.
Published: (2023-01-01)

Azithromycin Place in the Therapy of Community-Acquired Pneumonia in Children
by: S.A. Kramarev
Published: (2013-03-01)

Place of azithromycin in the treatment of community-acquired pneumonia in children
by: S.A. Kramarov, et al.
Published: (2020-02-01)

Are new antibiotics better than beta-lactams for non-critical inpatients with community-acquired pneumonia?
by: Tomás Reyes B., et al.
Published: (2016-09-01)

Effects of clarithromycin treatment in scrub typhus in children: comparison with chloramphenicol and azithromycin
by: Min Lee, et al.
Published: (2017-04-01)

Levofloxacin versus ceftriaxone and azithromycin for treating community-acquired pneumonia: a randomized clinical trial study
by: Davood Yadegarynia, et al.
Published: (2022-08-01)

Pharmacokinetics of Macrolide Antibiotics and Transport into the Interstitial Fluid: Comparison among Erythromycin, Clarithromycin, and Azithromycin
by: Shinji Kobuchi, et al.
Published: (2020-04-01)

Pharmacokinetic optimisation of beta-lactams for the treatment of ventilator-associated pneumonia
by: G. L. Drusano
Published: (2007-08-01)

Predicting Oral Beta-lactam susceptibilities against Streptococcus pneumoniae
by: Mark E. Murphy, et al.
Published: (2021-07-01)

Cryptogenic organizing pneumonia-Results of treatment with clarithromycin versus corticosteroids-Observational study.
by: Elżbieta Radzikowska, et al.
Published: (2017-01-01)

Expression comparison of azithromycin and clarithromycin in triple-therapy regimens for eradication of Helicobacter pylori in hemodialysis patients
by: Jamshid Vafaeimanesh, et al.
Published: (2014-01-01)

Inducible and Acquired Clarithromycin Resistance in the Mycobacterium abscessus Complex.
by: Marc Rubio, et al.
Published: (2015-01-01)

Management of Macrolide Antibiotics (Erythromycin, Clarithromycin and Azithromycin) in the Environment: A Case Study of Environmental Pollution in Lithuania
by: Inga Baranauskaite-Fedorova, et al.
Published: (2022-12-01)

Azithromycin: A promising treatment option for Mycobacterium avium complex pulmonary disease in case of intolerance to clarithromycin
by: Kengo Oshima, et al.
Published: (2021-12-01)

Risk factors for mortality of patients with ceftriaxone resistant E. coli bacteremia receiving carbapenem versus beta lactam/beta lactamase inhibitor therapy
by: Nosheen Nasir, et al.
Published: (2019-09-01)

Intravenous azithromycin plus ceftriaxone followed by oral azithromycin for the treatment of inpatients with community-acquired pneumonia: an open-label, non-comparative multicenter trial
by: Fernando G. Rubio, et al.

Risk of Mortality and Cardiovascular Events in Patients with Chronic Obstructive Pulmonary Disease Treated with Azithromycin, Roxithromycin, Clarithromycin, and Amoxicillin
by: Imane Achir Alispahic, et al.
Published: (2024-03-01)

The Survey of Genes Encoding Beta-Lactamases, in Escherichia Coli Resistant to Beta-Lactam and Non-Beta-Lactam Antibiotics
by: Fereshteh Shahcheraghi, et al.
Published: (2010-01-01)

THE ASYMMETRIC-SYNTHESIS OF BETA-LACTAMS
by: Blackburn, B, et al.
Published: (1987)

The enzymes of beta-lactam biosynthesis
by: Hamed, R, et al.
Published: (2013)

Evaluation of the Effect of Comorbidity on the Efficacy and Safety of β-Lactam Antibiotics in Patients with Community-Acquired Pneumonia
by: O. V. Muslimova, et al.
Published: (2022-07-01)

Panel strain of Klebsiella pneumoniae for beta-lactam antibiotic evaluation: their phenotypic and genotypic characterization
by: Roshan Dsouza, et al.
Published: (2017-01-01)

Beta lactam resistance in MDR CC320 Serogroup 19 Streptococcus pneumoniae in India
by: R. Varghese, et al.
Published: (2020-12-01)

Efflux pump, the masked side of beta-lactam resistance in Klebsiella pneumoniae clinical isolates.
by: Jean-Marie Pages, et al.
Published: (2009-01-01)

Medication Therapy Management Clinics: A Model to Improve Healthcare Access
by: Rizah Anwar Assadi, et al.
Published: (2021-08-01)

Reversible acylation of elastase by gamma-lactam analogues of beta-lactam inhibitors
by: Westwood, N, et al.
Published: (1997)

Pharmacodynamic Thresholds for Beta-Lactam Antibiotics: A Story of Mouse Versus Man
by: Angela V. Berry, et al.
Published: (2022-03-01)

Clarithromycin use for adjunct surgical prophylaxis before non-elective cesarean deliveries to adapt to azithromycin shortages in COVID-19 pandemic.
by: Daniel Martingano, et al.
Published: (2020-01-01)

Role of clarithromycin in ventilator-associated pneumonia care bundle in the prevention of ventilator-associated pneumonia
by: Ashraf A H. Mahmoud, et al.
Published: (2020-01-01)

Doxycycline vs. macrolides in combination with a β-lactam antibiotic for the treatment of community-acquired pneumonia in inpatients
by: Raghad K. Aldhahri, et al.
Published: (2022-12-01)